Lonza

📈 Weekend listening: Optimizing oral solid dosages! 🎧 Looking to enhance your drug's performance and meet patient needs? In this exclusive PharmTech video, Lonza's Adi Kaushal breaks down the latest trends in the #OralSolidDosage market. He shares insights on: * Overcoming development challenges for #OSD. * Leveraging expert techniques to boost #bioavailability. * Future advancements shaping drug delivery. Don't miss this valuable discussion for drug developers! 👉 Watch the full interview here: https://lnkd.in/di_ZZYh8 #PharmaTech #DrugDelivery #Lonza #ExpertInsight #Bioavailability

Lonza and Ethris are joining forces to develop room-temperature stable, spray-dried mRNA vaccines for respiratory disease prevention. This collaboration is a game-changer for vaccine accessibility and distribution, eliminating cold chain reliance and enabling needle-free delivery. Lonza's Kimberly Shepard and Ethris's Carsten Rudolph, Dr. share the full story and vision in this Q&A article. Read all about this exciting advancement: https://lnkd.in/eJVkUGuE #VaccineDevelopment #mRNA #Lonza #Ethris #Healthcare #Innovation

Are unexpected hurdles and costly delays derailing your promising biotherapeutic candidates? Join our upcoming webinar, "Building Better Biologics: Early strategies for optimizing the progression of biotherapeutic candidates to first in human studies and beyond," on June 9th at 11:00am EDT. Raymond Donninger will explore how strategic application of advanced technologies – from in silico immunogenicity and manufacturability prediction to scalable expression systems like the GS Gene Expression System® – can optimize candidate selection, enhance manufacturability, and dramatically reduce downstream development risks. Our goal? To help you achieve higher success rates and smarter resource investment. Register here: https://lnkd.in/eg39iWxk #IntegratedBiologics #Biotherapeutics #FirstinHuman

We are thrilled to announce the release of our latest application note: Rapid Cocoon® CAR-T™: rapid manufacturing of CAR-T cells with integrated selection in the Cocoon® Platform ⬇️ https://lnkd.in/eVZGFN3a In this article we describe how the Cocoon® Platform enables rapid CAR-T manufacturing directly from apheresis material without need for pre-processing. The Rapid Cocoon® CAR-TTM products show robust memory and activation profiles and strong cytotoxicity. Download the app note and discover how the Cocoon® platform can automate and shorten CAR-T manufacturing workflows. #CocoonPlatform #LonzaCGT #CellTherapy

We’re excited to share that Salvatore Mercuri, Head of NPI & MSAT, and Ilaria Valente, Technical Sales Manager, will be attending the DCAT (Drug, Chemical & Associated Technologies Association) Summit in Lugano on June 4–5! This is a great opportunity to connect with key players across the pharma and biotech space—and we’re looking forward to the conversations around innovation, collaboration, and what’s next for our industry. 📅 Planning to attend? Don’t hesitate to reach out and connect with Salvatore or Ilaria. They’ll be happy to discuss how Lonza can help accelerate your molecule’s journey from concept to market. Let’s connect in Lugano! #Lonza #DCATSummit2025 #PharmaInnovation #Biotech #CDMO #DCAT

Ready to accelerate your innovation at #BIO2025? Our team is gearing up for an incredible week of collaboration, discovery, and a few good coffee chats at Booth 266. Find out what to expect from the Lonza team at the BIO International Convention here 👉 https://lnkd.in/eUftcyKm #lonza #biologics

Could a capsule replace your injection? Discover Biograil’s smart capsule technology — a spring-loaded pill that delivers biologics directly into the stomach lining like a bee stinger — no needles needed. A promising future for chronic care and patient convenience. Listen here, or wherever you usually get your podcasts: https://lnkd.in/dscXsCZt #DrugDelivery #PharmaInnovation #Biologics #SmartCapsule #AViewOn #Lonza

📰 Weekend read Navigating the evolving pharmaceutical landscape, understanding the integration of cutting-edge technology into drug development and manufacturing is crucial. "Drug services firms begin embracing AI" (https://lnkd.in/dSXGGBxa) article from C&EN offers valuable insights into how leading CDMOs are leveraging AI and automation to enhance efficiency, accelerate timelines, and ensure superior quality in drug synthesis and quality control.🔬✨ As highlighted by our colleague Jan Vertommen, PhD, these advancements directly impact the speed and reliability of bringing critical therapies to market. A valuable read to understand the future of our drug development.

Heading to the Global Drug Delivery & Formulation Summit 2025? Don’t miss Adi Kaushal’s talk on Wednesday, 4 June: "Sustainable and Integrated Pathway to Material-Sparing ASD Formulation and Process Development." Adi will explore how a material-sparing hot melt extrusion (HME) screening approach enables efficient, parallel assessment with spray-dried dispersions. He’ll also cover sustainable innovations in ASD manufacturing. We’re looking forward to connecting. Come meet us at Booth 13. Join us at the #DDFSummit to hear how we are helping our customers advance their challenging molecules, faster. #DrugDelivery #HotMeltExtrusion #AdvancedSynthesis #DDFSummit

We have just launched our Design2Optimize™ platform, to enhance the process development and manufacturing of small molecule APIs. The platform helps to address the challenge of increasingly complex small molecule API routes, which now often consist of at least 20 synthetic steps. It helps drug developers to build predictive models at speed, even for complex or poorly understood reactions where the mechanism is not definitively known. By generating a digital twin of each process, the platform enables scenario testing in situ without the need for further physical experimentation. Combining the Design2Optimize™ platform with Lonza’s award-winning AI-enabled route scouting service and high-throughput experimentation (HTE) to rapidly test and compare reaction conditions, Lonza’s integrated approach streamlines development, enhances process understanding, and accelerates the journey from molecule design to market. Read more here: https://lnkd.in/dCtbjRrA #Lonza #PharmaceuticalInnovation #SmallMoleculeAPI #ProcessDevelopment #DrugDevelopment